11/21
12:10 pm
pfe
IWBI Announces Inaugural Social Sustainability Summit in New York [Yahoo! Finance]
Low
Report
IWBI Announces Inaugural Social Sustainability Summit in New York [Yahoo! Finance]
11/21
09:09 am
pfe
Is Pfizer Stock A Sell With Vaccine Skeptic Robert F. Kennedy Jr. Tapped To Lead HHS? [Yahoo! Finance]
Low
Report
Is Pfizer Stock A Sell With Vaccine Skeptic Robert F. Kennedy Jr. Tapped To Lead HHS? [Yahoo! Finance]
11/21
08:06 am
pfe
Gummy Vitamin Market is Projected to Climb of $7.18 Billion with 5.1% CAGR by 2034 | Fact.MR Reports [Yahoo! Finance]
Low
Report
Gummy Vitamin Market is Projected to Climb of $7.18 Billion with 5.1% CAGR by 2034 | Fact.MR Reports [Yahoo! Finance]
11/21
06:20 am
pfe
Patients, Scientists Agree: Automated Red Blood Cell Exchange Enhances Quality of Life in Sickle Cell Disease Patients [Yahoo! Finance]
Low
Report
Patients, Scientists Agree: Automated Red Blood Cell Exchange Enhances Quality of Life in Sickle Cell Disease Patients [Yahoo! Finance]
11/21
05:39 am
pfe
Clinical Nutrition for Cancer Care: Assessment of the Global Market with Regional Growth Projections to 2033 and Analysis of Leading Industry Players Including Pfizer, Bayer, and Abbott Nutrition [Yahoo! Finance]
Low
Report
Clinical Nutrition for Cancer Care: Assessment of the Global Market with Regional Growth Projections to 2033 and Analysis of Leading Industry Players Including Pfizer, Bayer, and Abbott Nutrition [Yahoo! Finance]
11/21
04:39 am
pfe
2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years [Yahoo! Finance]
Low
Report
2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years [Yahoo! Finance]
11/21
04:34 am
pfe
EC marketing authorisation granted to Pfizer's HYMPAVZI for haemophilia [Yahoo! Finance]
Low
Report
EC marketing authorisation granted to Pfizer's HYMPAVZI for haemophilia [Yahoo! Finance]
11/21
04:07 am
pfe
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam) [Yahoo! Finance]
Low
Report
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam) [Yahoo! Finance]
11/20
11:19 am
pfe
If You'd Invested In These 5 Stocks Before the Last Inauguration Day, Here's How Much They'd Be Worth Now [Yahoo! Finance]
Low
Report
If You'd Invested In These 5 Stocks Before the Last Inauguration Day, Here's How Much They'd Be Worth Now [Yahoo! Finance]
11/20
11:19 am
pfe
Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief [Yahoo! Finance]
Low
Report
Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief [Yahoo! Finance]
11/20
09:18 am
pfe
Avenzo Therapeutics Announces Appointment of Patrick Machado, J.D. to Board of Directors as Independent Director [Yahoo! Finance]
Low
Report
Avenzo Therapeutics Announces Appointment of Patrick Machado, J.D. to Board of Directors as Independent Director [Yahoo! Finance]
11/20
09:08 am
pfe
Ultromics obtains Breakthrough Device FDA clearance for its Cardiac Amyloidosis screening device through the Total Product Lifecycle Advisory Program [Yahoo! Finance]
Low
Report
Ultromics obtains Breakthrough Device FDA clearance for its Cardiac Amyloidosis screening device through the Total Product Lifecycle Advisory Program [Yahoo! Finance]
11/20
08:36 am
pfe
Pfizer Names New R&D Chief [Yahoo! Finance]
Low
Report
Pfizer Names New R&D Chief [Yahoo! Finance]
11/20
08:13 am
pfe
Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies [Yahoo! Finance]
Low
Report
Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies [Yahoo! Finance]
11/20
08:13 am
pfe
Unnatural Products Appoints Simon Bailey, Ph.D., as Chief Operating Officer and President of R&D [Yahoo! Finance]
Low
Report
Unnatural Products Appoints Simon Bailey, Ph.D., as Chief Operating Officer and President of R&D [Yahoo! Finance]
11/20
08:02 am
pfe
Pfizer names insider Chris Boshoff as R&D chief [CNBC]
Low
Report
Pfizer names insider Chris Boshoff as R&D chief [CNBC]
11/20
07:39 am
pfe
Metastatic Colorectal Cancer Market Forecast to Reach US$ 9,787.5 Million by 2034, Growing at 5.1% CAGR | Fact.MR Report [Yahoo! Finance]
Low
Report
Metastatic Colorectal Cancer Market Forecast to Reach US$ 9,787.5 Million by 2034, Growing at 5.1% CAGR | Fact.MR Report [Yahoo! Finance]
11/20
07:17 am
pfe
Flagship, Pfizer alliance yields two more startup deals [Yahoo! Finance]
Low
Report
Flagship, Pfizer alliance yields two more startup deals [Yahoo! Finance]
11/20
06:46 am
pfe
Pfizer Announces New Chief Scientific Officer and President, Research & Development [Yahoo! Finance]
Low
Report
Pfizer Announces New Chief Scientific Officer and President, Research & Development [Yahoo! Finance]
11/20
06:45 am
pfe
Pfizer Announces New Chief Scientific Officer and President, Research & Development
Low
Report
Pfizer Announces New Chief Scientific Officer and President, Research & Development
11/20
06:34 am
pfe
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer [Yahoo! Finance]
Low
Report
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer [Yahoo! Finance]
11/20
06:30 am
pfe
Pfizer names insider Chris Boshoff as R&D chief [Yahoo! Finance Canada]
Low
Report
Pfizer names insider Chris Boshoff as R&D chief [Yahoo! Finance Canada]
11/20
06:01 am
pfe
Is It Time to Sell Eli Lilly and Pfizer Stocks? [Yahoo! Finance]
Low
Report
Is It Time to Sell Eli Lilly and Pfizer Stocks? [Yahoo! Finance]
11/20
04:00 am
pfe
European Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors
Low
Report
European Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors
11/20
03:11 am
pfe
Pfizer Inc. (NYSE: PFE) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Pfizer Inc. (NYSE: PFE) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.